Programme 2017

  • 7.30

    Registration

  • 8.00

    Welcome

    Dr Tim Glenie, Chairman

 
SESSION ONE

  • 8.15

    Looking back to look forward

    Dr Tim Glenie
  • 8.30

    PCSK9 inhibitor – where are we at?

    Dr Warwick Jaffe
  • 8.50

    Anticoagulation for AF patient with CAD and stents.

    Dr Albert Ko
  • 9.10

    BioVascular Scaffolds (BVS)

    Dr Douglas Scott
  • 9.20

    Novel devices in medical practice

    Dr Patrick Gladding
  • 9.35

    Novel Heart Failure therapies

    Dr Hitesh Patel
  • 9.50

    Morning wrap up

    Dr Tim Glenie

  • 10.00

    Morning tea


 

SESSION TWO

  • 10.30

    GP led Interactive Case Studies in breakout rooms

  • Room 1

    Atypical chest pain diagnosis

    Dr Ko
    Dr Glenie
  • Room 2

    The breathless patient

    Dr Scott
    Dr Wong
  • Room 3

    Risk Factor Management- managing patient compliance

    Dr Jaffe
    Dr Patel

 

SESSION THREE

  • 11.15

    GP led Interactive Case Studies in breakout rooms

  • Room 1

    The breathless patient

    Dr Scott
    Dr Wong
  • Room 2

    Risk Factor Management- managing patient compliance

    Dr Jaffe
    Dr Patel
  • Room 3

    Atypical chest pain diagnosis

    Dr Ko
    Dr Glenie

 

SESSION FOUR

  • 12.00

    GP led Interactive Case Studies in breakout rooms

  • Room 1

    Risk Factor Management- managing patient compliance

    Dr Jaffe
    Dr Patel
  • Room 2

    Atypical chest pain diagnosis

    Dr Ko
    Dr Glenie
  • Room 3

    The breathless patient

    Dr Scott
    Dr Wong

 


  • 12.45

    Lunch


 

SESSION FIVE

  • 1.30

    AF ablation indications

    Dr Andrew Gavin
  • 1.45

    New advances in cardiac imaging

    Dr Selwyn Wong
  • 2.00

    New diabetic medications and the promise of improved Cardiovascular outcomes

    Dr Mark Webster
  •  
  • 2.15

    Discussion -Take Home Messages Closing Remarks

    Dr Tim Glenie
  • 2.30

    Close

 
 
 


 

Provided by The Ascot Cardiology Group   The Ascot Research and Education Trust   Ascot Angiography Ltd